[{"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":169279089.0,"RevenuesConverted_1_Q2_USD":910800000.0,"RevenuesConverted_2_Q2_USD":1756500000.0,"NetIncomeLossConverted_2_Q2_USD":145400000.0,"CommonStockSharesConverted_0_Q2_shares":170133258.0,"Assets_0_Q2_USD":8198100000.0,"EarningsPerShareBasic_2_Q2_USD":0.88,"StockholdersEquity_0_Q2_USD":3455500000.0,"EarningsPerShareDiluted_2_Q2_USD":0.87,"EarningsPerShareDiluted_1_Q2_USD":0.45,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":223700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":165589730.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":167075141.0,"StockholdersEquityConverted_0_Q2_USD":3455500000.0,"NetIncomeLossConverted_1_Q2_USD":88400000.0,"CommonStockSharesOutstanding_0_Q2_shares":170133258.0,"EarningsPerShareBasic_1_Q2_USD":0.46,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20201231","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20210202"}]